Read + Share
Lu S, Zhang Y, Zhang G, Zhou J, et al. Befotertinib for patients with pretreated EGFR T790M mutated locally advanced or
metastatic NSCLC: Final overall survival results from a phase 2 trial. Lung Cancer 2024;195:107901.
PMID: 39089004
|
 |
|
Lu S, Zhang Y, Zhang G, Zhou J, et al. Befotertinib for patients with pretreated EGFR T790M mutated locally advanced or
metastatic NSCLC: Final overall survival results from a phase 2 trial. Lung Cancer 2024;195:107901.
PMID: 39089004
|
|
|
|